Kedoya Adyaraya Tbk PT

The company's capital structure is characterized by a debt-to-equity ratio of 0.18, indicating a relatively low reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.0, suggesting that the company has just enough current assets to cover its current liabilities. The price-to-book ratio of 1.35 and the price-to-tangible-book ratio of 1.35 indicate that the company's market value is slightly above its book value. In terms of profitability, the company's return on equity (ROE) is 4.16%, and its return on assets (ROA) is 3.18%, which are metrics that reflect the efficiency of the company in generating profits from its equity and assets, respectively. These figures should be compared against the industry median to determine if the company is outperforming or underperforming its peers. The company's revenue is concentrated in Indonesia, and it operates through several subsidiaries, including PT Daya Guna Usaha, PT Sinar Medika Sejahtera, and PT Sinar Medika Sutera Dahulu. The geographic exposure is primarily within the domestic market, and the company's services are spread across various healthcare segments, such as Trauma Center, Stroke Care, and Cardiology Center. The company's growth trajectory is reflected in its revenue of 469,592,692,610 IDR and its net income of 34,507,058,540 IDR. The outlook for the current fiscal year and the next fiscal year is not explicitly provided, but the company's operating cash flow of 90,246,003,650 IDR and free cash flow of 22,724,769,250 IDR suggest a positive cash flow position. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's capital expenditure of -50,801,871,650 IDR suggests that it is investing in its operations, which could be a sign of growth or expansion. The risk of dilution is low, and the company's shares outstanding are the same for both basic and diluted shares, indicating no significant dilution potential. Recent events and filings have not been explicitly detailed in the provided data, but the company's financial snapshot and valuation metrics provide a current view of its financial health. The company's recent performance and strategic initiatives, such as the introduction of robotic assisted rehabilitation therapy tools, may influence its future financial performance.